Dr Sarini Ettigi, PHD | |
90 Guardian Ct, Rocky Mount, NC 27804-3017 | |
(252) 212-3350 | |
(252) 822-5065 |
Full Name | Dr Sarini Ettigi |
---|---|
Gender | Female |
Speciality | Psychologist - Counseling |
Location | 90 Guardian Ct, Rocky Mount, North Carolina |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841826492 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC1900X | Psychologist - Counseling | 5691 (North Carolina) | Primary |
103T00000X | Psychologist | 5691 (North Carolina) | Secondary |
Entity Name | Inpatient Consultants Of North Carolina Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669422846 PECOS PAC ID: 5991720591 Enrollment ID: O20051012001172 |
News Archive
In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Nuevolution A/S today announced that it has entered into collaboration with Boehringer Ingelheim, using Nuevolution's proprietary Chemetics® drug discovery technology. Within the framework of the collaboration, hundreds of millions of diverse small molecules will be screened to discover and advance drug candidates against drug targets of interest to Boehringer Ingelheim.
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.
› Verified 9 days ago
Entity Name | Opportunities Industrialization Center, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396103305 PECOS PAC ID: 3173563590 Enrollment ID: O20161104000262 |
News Archive
In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Nuevolution A/S today announced that it has entered into collaboration with Boehringer Ingelheim, using Nuevolution's proprietary Chemetics® drug discovery technology. Within the framework of the collaboration, hundreds of millions of diverse small molecules will be screened to discover and advance drug candidates against drug targets of interest to Boehringer Ingelheim.
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.
› Verified 9 days ago
Entity Name | Nm Pacs 2 Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366928749 PECOS PAC ID: 3375892060 Enrollment ID: O20200109003016 |
News Archive
In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Nuevolution A/S today announced that it has entered into collaboration with Boehringer Ingelheim, using Nuevolution's proprietary Chemetics® drug discovery technology. Within the framework of the collaboration, hundreds of millions of diverse small molecules will be screened to discover and advance drug candidates against drug targets of interest to Boehringer Ingelheim.
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Sarini Ettigi, PHD Po Box 2723, Rocky Mount, NC 27802-2723 Ph: (252) 212-6802 | Dr Sarini Ettigi, PHD 90 Guardian Ct, Rocky Mount, NC 27804-3017 Ph: (252) 212-3350 |
News Archive
In a post in the Center for Global Development's (CGD) "Global Health Policy" blog, Owen Barder, a senior fellow and director for Europe at the CGD, reports on the results of a large Phase III clinical trial conducted in Africa on the malaria vaccine candidate RTS,S, published online in the New England Journal of Medicine on Friday.
Consumers coping with the high cost of health insurance are the target market for new plans claiming to be lower-cost alternatives to the Affordable Care Act that fulfill the law's requirement for health coverage.
Nuevolution A/S today announced that it has entered into collaboration with Boehringer Ingelheim, using Nuevolution's proprietary Chemetics® drug discovery technology. Within the framework of the collaboration, hundreds of millions of diverse small molecules will be screened to discover and advance drug candidates against drug targets of interest to Boehringer Ingelheim.
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer - abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating - when combined with the CA125 blood test may improve the early detection of ovarian cancer by 20 percent, according to new findings by researchers at Fred Hutchinson Cancer Research Center published online today in CANCER.
› Verified 9 days ago
Dr. Rosanna Lora, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 90 Guardian Ct, Rocky Mount, NC 27804 Phone: 252-212-3350 Fax: 252-212-0322 | |
Ms. Charlotte Reeves Walyko, MA, LPA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 854 Country Club Rd, Rocky Mount, NC 27804 Phone: 252-972-9903 Fax: 252-451-1540 | |
Mr. Le'marus Perez Alston, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3400 N Wesleyan Blvd, Rocky Mount, NC 27804 Phone: 252-567-4922 | |
Ms. Lori Dawn Chambers, M.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 141 Storage Rd, Rocky Mount, NC 27804 Phone: 252-443-0318 Fax: 252-443-5079 | |
Ms. Jennifer Waters Williams, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 878 Country Club Rd, Rocky Mount, NC 27804 Phone: 252-314-7021 | |
Mrs. Carolyn Robards Eggers, M.A., C.A.S. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 852 Country Club Rd, Rocky Mount, NC 27804 Phone: 252-443-4401 | |
Edwina B. Garrett, M.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 107 S.e. Main Street, Suite 410, Rocky Mount, NC 27801 Phone: 252-442-5771 Fax: 252-442-5780 |